So looks like consensus here will be (.37)/sh.
I used Q4 expense of 24.75M and revenue guidance of 14.8-15.6M. Playing with the numbers I get a Q1 EPS range of (.35)-(.43)/sh. So they may actually come in close to consensus this Q.
Hard to be certain with only revenue guidance to work with. I know, broken record.
What are you seeing?
Ann: AVITA Medical Q4 2023 Investor Presentation, page-34
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.63 |
Change
0.160(6.48%) |
Mkt cap ! $174.3M | |||
| Open | High | Low | Value | Volume |
| $2.54 | $2.64 | $2.54 | $768.3K | 296.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5253 | $2.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.63 | 3793 | 1 |
View Market Depth
| Last trade - 13.42pm 12/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |